Abstract:The high mutation rate of the hepatitis C virus (HCV) genome increases the genotype diversity and renders the detection of the virus more difficult. Therefore, prediction and assessment of highly conserved and strongly antigenic epitope polypeptide sequences have become a focus of current research. The E2 region is the target binding region of neutralizing antibodies. HCV genomics, especially the high mutation rate of E2 region sequence, makes its genotyping more and more diverse, and the detection of HCV and genotype is becoming more and more strict. In this study, four HCV B cell epitope polypeptides were constructed based on assessment of conserved sequences in the HCV E2 region and prediction of B cell epitopes, including sequences specific to genotype 1A (DC-13: 434-DTGWLAGLFYYHK-446), genotype 1B (HC-13: 434-HTGFLAALFYAKS-446), genotype 4D (NC-13: 434-NTGFLASLFYTHK-446), and a consensus sequence (FC-9: 447-FNSSGCPER-455). Epitope polypeptides combined with serum from 29 HCV-infected or 25 non-HCV-infected individuals were assayed by enzyme-linked immunosorbent assay (ELISA), and differences were analyzed by T/T' test methods in SPSS v20.0 software. Binding levels of genotype 1A, 4D, and consensus epitope polypeptides with sera of HCV-infected patients were higher than those of non-infected individuals. Moreover, binding of genotype 1B epitope polypeptides with serum of HCV 1B-infected patients was higher than that of HCV 2A-infected patients. While the screening results of HCV genotype-specific epitope polypeptides were preliminary, these findings indicated that we successfully established an HCV and genotype serological ELISA detection method. Such an approach would facilitate the discovery of epitope polypeptides which may become new antigen candidates in peptide vaccine development for the prevention of HCV infection.

[Eukaryotic expression and application of HCV Hebei strain E2 extracellular core region].

Expression of Hepatitis C Virus E2 Ectodomain in E. Coli and Its Application in the Detection of Anti-E2 Antibodies in Human Sera

Construction and Expression of Eukaryotic Expression Plasmid of Core Gene of Hepatitis C Virus

Cloning,Expression of E2 Gene in Hepatitis C Virus Envelope Region and Significance of Anti-HCV E2 Detection in Patients with HCV Infection

Expression of Hepatitis C Virus H Strain Envelope Glycoprotein in Insect Cells

Purification and Application of C-terminally Truncated Hepatitis C Virus E1 Proteins Expressed in Escherichia Coli.

Expression of Hepatitis C Virus Core Protein in E.coli

Expression of HCV core gene and protein purification

Expression and Characterization of Hepatitis C Virus E2 Glycoprotein Fused to Hepatitis B Virus Pres1(21-47) Fragment in CHO Cells

Prokaryotic Expression and Purification of Truncated Hepatitis C Virus Envelope Glycoprotein E2

Expression of E1 Gene of a Hepatitis C Virus Ine. Coli and Protein Purification

Expression of HCV multiepitopes gene in E.coli and analysis of its immunological characteristics

Expression of Truncated Form of HCV Glycoprotein E2 and Assay of Activation of Reporter Genes in Yeast Two-hybrid System

Expression And Preliminary Application Of Hcvf Protein Gene

High-level Expression of the C-terminal Hydrophobic Region of HCV E2 Protein Ectodomain in E. coli

Retroviral Vector Mediated HCV E1E2 Envelope Protein Expression in Eukaryotic Cells and Animal Immune Experiment

Expression of Soluble Human ScFv Against Envelope Protein E2 of Hepatitis C Virus Antigen in E.coli.

[Expression, Purification and Immunogenicity of a Novel Hepatitis E Virus-Like Particle].

[Expression of Hepatitis C Virus Envelope Proteins with a Recombinant Baculovirus Expression System].

Expression of HCV Structural Protein in Mammalian Cells

Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region